 |
Top 28 medical and healthcare startups in South Korea
Oct 12, 2024 | By Jason Kwon | 28 |
1
Funding: $24.8M
Medi Whale offers medical AI software for eye disease detection. Its devices assess cardiovascular risk through the use of retinal imagery and artificial intelligence
Medi Whale offers medical AI software for eye disease detection. Its devices assess cardiovascular risk through the use of retinal imagery and artificial intelligence
2
Funding: $561.1M
Lunit is a medical technology company that specializes in developing and providing AI-powered medical imaging solutions. It also provides its infrastructure on military warships.
Lunit is a medical technology company that specializes in developing and providing AI-powered medical imaging solutions. It also provides its infrastructure on military warships.
3
Funding: ₩550B
Lego Chem Bioscience is a company created by people with dreams and enthusiasm for global new drug development
Lego Chem Bioscience is a company created by people with dreams and enthusiasm for global new drug development
4
Funding: $137M
D&D Pharmatech is a biotech company that funds the development of revolutionary medicines through disease-specific subsidiary companies founded and guided by top-tier medical research faculty. This corporate structure creates a unique opportunity to accelerate translation of cutting-edge research into lifesaving therapeutic products for patients. The company’s product pipeline focuses on a range of indications including neurodegenerative and fibrotic diseases.
D&D Pharmatech is a biotech company that funds the development of revolutionary medicines through disease-specific subsidiary companies founded and guided by top-tier medical research faculty. This corporate structure creates a unique opportunity to accelerate translation of cutting-edge research into lifesaving therapeutic products for patients. The company’s product pipeline focuses on a range of indications including neurodegenerative and fibrotic diseases.
6
Funding: $44.6M
Genome & Company is a clinical stage biotechnology company based in Republic of Korea that focuses on discovering and developing the next waves of innovative therapeutics in immuno-oncology through diverse modalities of microbiome, novel target immune checkpoint inhibitors and fusion proteins to fulfill the unmet needs of cancer patients.
Genome & Company is a clinical stage biotechnology company based in Republic of Korea that focuses on discovering and developing the next waves of innovative therapeutics in immuno-oncology through diverse modalities of microbiome, novel target immune checkpoint inhibitors and fusion proteins to fulfill the unmet needs of cancer patients.
8
Funding: $42M
Sky Labs is developing a smart ring-like device called CART (Cardio Tracker) that is capable of diagnoising and managing atrial fibrillation (AF) — a form of heart disease that results in irregular heartbeat rhythms.
Sky Labs is developing a smart ring-like device called CART (Cardio Tracker) that is capable of diagnoising and managing atrial fibrillation (AF) — a form of heart disease that results in irregular heartbeat rhythms.
9
Funding: $39.6M
ChunLab is a big data platform-based microbiome company with microbial bioinformatics analytics cloud platform, drug discovery platform leading a number of novel candidates for oncology and other diseases, genome-based diagnostics for bacterial infection.
ChunLab is a big data platform-based microbiome company with microbial bioinformatics analytics cloud platform, drug discovery platform leading a number of novel candidates for oncology and other diseases, genome-based diagnostics for bacterial infection.
10
Funding: $37.6M
Ilias Biologics is developing various therapeutic exosomes, a potential treatment for sepsis, pre-term birth, and various hard-to-treat diseases in inflammatory and metabolic areas.
Ilias Biologics is developing various therapeutic exosomes, a potential treatment for sepsis, pre-term birth, and various hard-to-treat diseases in inflammatory and metabolic areas.
